| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |